Hanmi’s ‘Olita Tab’ issue lead bill to tighten safety of clinical trial

Published: 2016-11-29 11:26:33

Updated: 2016-11-29 11:26:33

While Hanmi Pharm’s Olita Tab encounter side effects of death during a clinical trial and is still causing issues, a bill to tighten safety of clinical trial was tabled.

On the 25^th, The Minjoo Party Rep. Jung Park announced he tabled an amendment to the Pharmaceutical Affairs Law to obligate for a pharmaceutical company to suspend a clinical trial and immediately make a report if encountering...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.